COUN 5223 Week 9 Assessment 1 Consultation, Supervision, and Advocacy Plan
Carla Liranzo
COUN 5223
Capella University
March 14, 2026
Attention Deficit Hyperactivity Disorder (ADHD) is often comorbid with substance use disorder (SUD) and presents a multitude of challenges for the provision of behavioral health services. These services must be delivered in an integrated manner to positively impact on the lives of those with co-occurring ADHD and SUD diagnoses. Common challenges faced by such people include emotional instability, academic and career nonperformance, and relapse into substance use. Research indicates that 25-30% of adults in SUD treatment programs have ADHD (Barbuti et al., 2023). This article provides a historical perspective of the clinical mental health counseling services provided to individuals diagnosed with ADHD and SUD. It examines the role of a community-based agency within the continuum of care, and presents models and strategies for the provision of on-site and outreach consultation, supervision, and advocacy services. Adolescents with attention-deficit/ hyperactivity disorder (ADHD), who subsequently develop substance use disorders (SUD), constitute a group with complicated mental health counseling requirements. Generally, the term adolescence is used to refer to persons aged 12 to 18 years, a stage of development where identity starts forming and becomes more vulnerable to risky behavior. Inattention, impulsivity, and problems with emotional management are the symptoms that adolescents with ADHD may experience. These traits have the capacity to predispose one to substance experimentation in adolescence. Studies show that there is a high rate of co-occurrence of ADHD and SUD that is higher than that which would be observed in the absence of environmental factors (Young et al., 2023). By combining both the ADHD symptoms and substance use behaviors into one, integrated counseling services can help such a population. By combining organized and effective treatment methods such as behavioral therapy, relapse-prevention methods, and medication follow-ups, counselors would be able to help teenagers develop self-control, decrease substance abuse, and increase the chances of long-term recovery. Ambrosia Behavioral Health is a behavioral health treatment facility based in South Florida, which provides a wide range of services to people with mental health problems and substance use disorders. The organization offers a range of evidence-based services, including standard outpatient counselling, intensive outpatient programs (IOPs), partial hospitalization programs (PHPs), and inpatient residential treatment. Individual therapy, group therapy, family counselling, medication management, and holistic therapies like mindfulness and wellness exercises are some of these services (Dfasam, 2026). As a result, Ambrosia Behavioural Health functions at several levels within the behavioural health continuum of care, especially in the areas of intensive outpatient services, residential treatment, and partial hospitalisation. For those who need more intensive treatment than standard outpatient therapy but might not need acute hospital-based psychiatric care, these programs offer structured therapeutic support. To ensure coordinated care, the agency collaborates with a range of healthcare professionals and community service providers across the continuum of mental health treatment. Clients experiencing severe psychiatric symptoms, medical complications, or crises may be referred to inpatient psychiatric hospitals for stabilization and 24-hour medical supervision. Clients who demonstrate improvement may then step down to intensive outpatient programs that provide structured therapy several days per week while allowing individuals to return to school, work, or family responsibilities (Isaacs & Duncan, 2025). Aftercare services such as relapse-prevention counselling, alumni recovery programs, and community mental health counselling further support long-term recovery and reduce the risk of relapse for individuals with co-occurring ADHD and substance use disorders. This consultation plan will use Caplan’s Mental Health Consultation Theory, specifically the Program-Centred Administrative Consultation Model and strategies. The strategies include needs assessment, interdisciplinary case consultation meetings, staff training in CBT and Motivational Interviewing (MI), and implementation of standardized ADHD and substance use screening tools. (Isaacs & Duncan, 2025). The consultation process will focus on improving coordinated services for adolescents experiencing co-occurring ADHD and SUD. Caplan’s consultation model emphasizes collaboration between consultants and agency professionals to strengthen clinical practices and improve treatment outcomes. The first step of the consultation will involve conducting a structured needs assessment to evaluate current treatment practices, referral systems, and staff competencies related to ADHD and substance use disorders (Dfasam, 2026). This will include reviewing treatment protocols, examining case documentation, and interviewing clinicians and administrators to identify gaps in coordinated care. The next phase will involve providing targeted training and consultation to clinical staff. Training will focus on evidence-based treatment approaches such as CBT and Motivational Interviewing, which are widely used for treating individuals with co-occurring mental health and substance use disorders. The consultation will also support the implementation of standardized screening tools to improve early identification of ADHD symptoms among clients entering substance use treatment programs (Balfour & Zeller, 2023). In addition, regular interdisciplinary case consultation meetings will be established to improve communication between counsellors, psychiatrists, addiction specialists, and case managers. Finally, the consultant will assist the agency in developing structured referral pathways between inpatient services, partial hospitalization programs, intensive outpatient programs, and aftercare recovery supports. These strategies will strengthen coordinated care and improve treatment outcomes for individuals receiving services for ADHD and substance use disorders. This supervision plan will use the Discrimination Model of Clinical Supervision, which defines supervisory roles and provides structured strategies for maintaining ethical and consistent client care. In this model, the clinical supervisor will take on three primary roles: teacher, counselor, and consultant. As a teacher, the supervisor offers guidance and education on evidence-based counseling practices for clients with co-occurring ADHD and SUD. As a counselor, the supervisor helps clinicians manage professional stress, emotional reactions, and challenges that may come up while working with high-risk dual-diagnosis clients (Balfour & Zeller, 2023). As a consultant, the supervisor works with clinicians to review treatment plans, discuss complex cases, and develop effective intervention strategies. These well-defined supervisory roles help ensure that counselors maintain professional competence, ethical practice, and consistent standards of care across the agency. Several supervision strategies will be in place to ensure client care is ethical and coordinated. First, clinicians will participate in weekly individual supervision sessions, where supervisors review case documentation, goals, and progress notes to ensure adherence to ethical standards and evidence-based treatment practices. Second, the agency will have biweekly group supervision sessions where counselors, case managers, and addiction specialists can discuss complicated cases and build interdisciplinary collaboration (Howard et al., 2022). Third, supervisors will introduce case consultation and treatment planning review to gauge that counseling interventions such as CBT and relapse-prevention counseling are being administered to individuals with ADHD and substance use disorder. Additional supervision strategies will include monitoring confidentiality, reviewing ethical decision-making processes, and ensuring medication coordination with psychiatrists. Professionals at the agency can take several advocacy steps at the state and national levels to reduce barriers that limit access, equity, and treatment success for adolescents experiencing co-occurring ADHD and SUD. Supporting policies that increase funding for integrated behavioral health programs that treat both mental health disorders and substance use disorders simultaneously is another significant advocacy step. Data received from the Substance Abuse and Mental Health Services Administration notes that most people with co-occurring disorders receive non-integrated services, thus creating gaps and increasing the risk of relapse (Howard et al., 2022). Mental health professionals can partner with national counseling bodies and behavioral health advocacy organizations to lobby for legislation that increases funding for community-based dual-diagnosis treatment programs. A significant advocacy initiative is focused on early detection of developmental ADHD and substance abuse risk, including both educational programs and primary health care services. Screening for the behavioral symptoms associated with diagnostic criteria for ADHD may lead to a decrease in the number of adolescents with substance abuse problems. By collaborating with policymakers and public health organizations, counselors and agency professionals can create state-based early detection programs for mental health services (Goes, 2025). This effort will likely result in fewer adolescents with substance abuse problems. Mental health professionals in the agency can also assist with advocating for broader insurance coverage and greater access to treatment. Many people with co-occurring ADHD and SUD face barriers related to inadequate insurance coverage, treatment costs, or lack of access to dedicated dual-diagnosis programs. Mental health professionals can assist with advocacy efforts to promote strong mental health parity laws and mandate insurance companies to provide coverage for comprehensive behavioral health services, including therapy, medication management, and long-term recovery support (Cheatham et al., 2026). By decreasing stigma and increasing public awareness, professionals can help provide more individuals with access to treatment and improve access to appropriate and effective mental health services for this population. Adolescents with comorbidity of ADHD and substance abuse have complicated needs that require combined, evidence-based counseling services. The historical trends in mental health care have shifted the therapeutic process to its interdisciplinary nature as a treatment aimed at behavioral modification and focused drug administration. Having orderly programs and creating cooperation with other specialists, agencies such as Ambrosia Behavioral Health are a crucial part of the continuum of care. Mental health professionals can be able to amplify service delivery, decrease barriers, and increase outcomes of this vulnerable population through careful consultation, supervision, and advocacy.Attention Deficient and Hyperactive Disorder co-occurring with Substance Use Disorder
Serving Individuals with ADHD co-occurring with SUD
In history, clinical mental health systems frequently treated adolescents with co-occurring ADHD and SUD independently. Previous treatment approaches frequently led to poor treatment outcomes and increased relapse rates because they addressed substance abuse counselling without addressing underlying ADHD symptoms. The new modern treatment methods have now focused on integrated and coordinated care, where clinicians can treat the symptoms of ADHD and substance-related behavior at the same time (Srichawla et al., 2022). One of the counseling interventions that has been very popular in the treatment of adolescents with comorbid ADHD and SUD is cognitive behavioral therapy (CBT). It assists them in adjusting their dysfunctional thinking, enhancing impulse control, and acquiring more effective coping skills. Additionally, research by Haugan (2022) emphasized the significance of carefully controlling stimulant medications, including the use of sustained-release or non-stimulant options, to lower the risk of SUD and ADHD. By promoting integrated, evidence-based treatment approaches that concurrently address substance abuse and ADHD symptoms among adolescents, these advancements had a substantial impact on contemporary clinical mental health counselling practices.Counseling Services across the Continuum of Care
Consultation Plan
Supervision Plan
Advocacy Steps to Reduce Barriers for Clients
Conclusion
Step-by-Step Instructions to write
COUN 5223 Week 9 Assessment 1
Contact us today and receive expert step-by-step instructions for COUN 5223 Week 9 Assessment 1.
Instructions File For
COUN 5223 Week 9 Assessment 1
Contact us to get the instruction file.
Scoring Guide For
COUN 5223 Week 9 Assessment 1
Contact us to get the scoring guide.
References in APA Format For
COUN 5223 Week 9 Assessment 1
Below are the references used in COUN 5223 Week 9 Assessment 1 Consultation, Supervision, and Advocacy Plan:
Balfour, M. E., & Zeller, S. L. (2023). Community-based crisis services, specialized crisis facilities, and partnerships with law enforcement. FOCUS the Journal of Lifelong Learning in Psychiatry, 21(1), 18–27. https://doi.org/10.1176/appi.focus.20220074
Barbuti, M., Maiello, M., Spera, V., Pallucchini, A., Brancati, G., Maremmani, A., Perugi, G., & Maremmani, I. (2023). Challenges of treating attention-deficit/hyperactivity disorder (ADHD) with comorbid substance use disorder: Considerations for the clinician. Journal of Clinical Medicine, 12(9), 3096. https://doi.org/10.3390/jcm12093096
Cheatham, L. P., Smith, N. L., & Gannon, B. S. (2026). Healthcare access among youth with disabilities leaving foster care: Exploring barriers in the deep South. Children and Youth Services Review, 183, 108791. https://doi.org/10.1016/j.childyouth.2026.108791
Cognitive behavioural group therapy as an addition to psychoeducation and pharmacological treatment for adolescents with attention-deficit/hyperactivity disorder (ADHD) symptoms and related impairments: a randomised controlled trial. BioMed Central Psychiatry, 22(1), 375. https://doi.org/10.1186/s12888-022-04019-6
Dfasam, D. A. M. D. (2026, March 12). Primary mental health treatment and Florida Drug rehab. Ambrosia Behavioral Health. https://www.ambrosiatc.com/
Goes, A. R. (2025). Advocacy for health and health equity: A call to public health professionals. Portuguese Journal of Public Health, 43(1), 1–4. https://doi.org/10.1159/000545038
Haugan, A.-L. J., Sund, A. M., Young, S., Thomsen, P. H., Lydersen, S., & Nøvik, T. S. (2022). Cognitive behavioral group therapy as an addition to psychoeducation and pharmacological treatment for adolescents with attention-deficit/hyperactivity disorder (ADHD) symptoms and related impairments: A randomized controlled trial. Biomed Central Psychiatry, 22(1), 375. https://doi.org/10.1186/s12888-022-04019-6
Howard, S., Alston, S., Brown, M., & Bost, A. (2022). Literature review on regulatory frameworks for addressing discrimination in clinical supervision. Research on Social Work Practice, 33(1), 84–96. https://doi.org/10.1177/10497315221121827
Isaacs, A. N., & Duncan, Z. (2025). Care coordination for persons with mental health challenges: A scoping review. International Journal of Mental Health Systems, 19(1), 24. https://doi.org/10.1186/s13033-025-00679-5
Srichawla, B. S., Telles, C. C., Schweitzer, M., & Darwish, B. (2022). Attention deficit hyperactivity disorder and substance use disorder: A narrative review. Cureus, 14(4), e24068. https://doi.org/10.7759/cureus.24068
Young, S., Abbasian, C., Al-Attar, Z., Branney, P., Colley, B., Cortese, S., Cubbin, S., Deeley, Q., Gudjonsson, G. H., Hill, P., Hollingdale, Jenden, S., Johnson, J., Judge, D., Lewis, A., Mason, P., Mukherjee, R., Nutt, D., Roberts, Cocallis, K. (2023). Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement. World Journal of Psychiatry, 13(3), 84–112. https://doi.org/10.5498/wjp.v13.i3.84
Best Capella professors to choose from for
COUN 5223 Class
- David J. Schlosz
- David Sarnoff
(FAQs) related to
COUN 5223 Week 9 Assessment 1
Question 1: What is COUN 5223 Week 9 Assessment 1 about?
Answer: Consultation, supervision, and advocacy plan for adolescents with co-occurring ADHD and SUD.
Question 2: Where can I get expert help with COUN 5223 Week 9 Assessment 1?
Answer 2: Get expert help with COUN 5223 Week 9 Assessment 1 from verified tutors at TutorsAcademy.co.
Do you need a tutor to help with this paper for you within 24 hours
- 0% Plagiarised
- 0% AI
- Distinguish grades guarantee
- 24 hour delivery

